Search - tctmd.com

Displaying 381 - 400 of 2029

Sort: Relevancy | Date

News Daily News

出院后发生出血的DES患者面临更高的死亡风险

Todd Neale

August 31, 2015

News Daily News

SES 骨折与长期结局恶化相关

August 31, 2015

News Daily News

SES Fracture Linked to Worse Long-term Outcomes

August 31, 2015

News Conference News ESC 2015

OPTIDUAL: No Clear Need to Lengthen DAPT to 4 Years After DES

Caitlin E. Cox

August 31, 2015

News Daily News

Los Pacientes SLF con Hemorragias Post-Alta Hospitalaria Corren un Mayor Riesgo de Mortalidad

Todd Neale

August 31, 2015

News Daily News

La Fractura del SLS se Asoció a Peores Resultados a Largo Plazo

August 31, 2015

News Daily News

DES Patients Who Bleed After Hospital Discharge Face Higher Mortality Risk

Todd Neale

August 31, 2015

News Industry News

Biotronik launches China arm in Orsiro stent trial

August 31, 2015

Presentation ESC 2015

12 vs 48 months of dual antiplatelet therapy after drug-eluting stent placement: The OPTIDUAL Randomized Trial

Presenter: G?rard Helft

August 31, 2015

Presentation

Stent Fracture After SES Implantation

Presenter: M. Ohya

August 28, 2015

Presentation

Incidence, Predictors, and Impact of Postdischarge Bleeding After PCI

Presenter: P. G?n?reux

August 28, 2015

News Daily News

登记研究表明 Absorb BVS 治疗所有糖尿病患者的效果与 DES 相当

August 27, 2015

News Daily News

Un Estudio de Registro Sugiere que AVB y SLF son Iguales en Pacientes Diabéticos No Seleccionados

August 27, 2015

News Daily News

Registry Study Suggests Absorb BVS Matches DES in Diabetic All-Comers

August 27, 2015

News Daily News

采用第二代 DES 的双支架策略在治疗分叉病变时无劣势

Yael L. Maxwell

August 26, 2015

News Daily News

No Disadvantage for 2-Stent Strategy in Bifurcation Lesions With Second-Generation DES

Yael L. Maxwell

August 26, 2015

News Daily News

La Estrategia de Doble Stent en Lesiones en Bifurcación con SLF de 2ª Generación No tiene Ninguna Desventaja

Yael L. Maxwell

August 26, 2015

Presentation

Implantation of Everolimus-Eluting Bioresorbable Scaffolds in a Diabetic All-Comers Population

Presenter: Jens Wiebe

August 26, 2015

Presentation

Differential Prognostic Effect of First- and Second-Generation DES in Coronary Bifurcation Lesions

Presenter: JM. Lee

August 25, 2015

News Industry News

Boston Scientific Announces FDA Approval of Innova™ Vascular Self-Expanding Stent System

August 19, 2015

Advertisement

出院后发生出血的DES患者面临更高的死亡风险

SES 骨折与长期结局恶化相关

SES Fracture Linked to Worse Long-term Outcomes

OPTIDUAL: No Clear Need to Lengthen DAPT to 4 Years After DES

Los Pacientes SLF con Hemorragias Post-Alta Hospitalaria Corren un Mayor Riesgo de Mortalidad

La Fractura del SLS se Asoció a Peores Resultados a Largo Plazo

DES Patients Who Bleed After Hospital Discharge Face Higher Mortality Risk

Biotronik launches China arm in Orsiro stent trial

12 vs 48 months of dual antiplatelet therapy after drug-eluting stent placement: The OPTIDUAL Randomized Trial

Stent Fracture After SES Implantation

Incidence, Predictors, and Impact of Postdischarge Bleeding After PCI

登记研究表明 Absorb BVS 治疗所有糖尿病患者的效果与 DES 相当

Un Estudio de Registro Sugiere que AVB y SLF son Iguales en Pacientes Diabéticos No Seleccionados

Registry Study Suggests Absorb BVS Matches DES in Diabetic All-Comers

采用第二代 DES 的双支架策略在治疗分叉病变时无劣势

No Disadvantage for 2-Stent Strategy in Bifurcation Lesions With Second-Generation DES

La Estrategia de Doble Stent en Lesiones en Bifurcación con SLF de 2ª Generación No tiene Ninguna Desventaja

Implantation of Everolimus-Eluting Bioresorbable Scaffolds in a Diabetic All-Comers Population

Differential Prognostic Effect of First- and Second-Generation DES in Coronary Bifurcation Lesions

Boston Scientific Announces FDA Approval of Innova™ Vascular Self-Expanding Stent System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content